Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APVO | AMGN | GILD | CELG | ILMN |
| Company | Aptevo Therapeutics Inc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.7200 | 265.64 | 67.01 | 108.01 | 116.25 |
| High | 0.7700 | 265.92 | 67.02 | 108.59 | 119.18 |
| Low | 0.7060 | 262.58 | 65.90 | 107.27 | 115.73 |
| Last | 0.7700 | 262.75 | 66.16 | 108.24 | 116.69 |
| Change | +0.0575 | -1.32 | -0.77 | +0.11 | -1.60 |
| % Change | +8.07% | -0.50% | -1.15% | +0.10% | -1.35% |
| Volume | 230,600 | 2,082,700 | 6,442,200 | 191,230,496 | 1,810,300 |
| 20-Day Average Volume | 516,145 | 2,201,900 | 6,214,910 | 16,188,930 | 1,527,960 |
| Previous Close | 0.7125 | 264.07 | 66.93 | 108.13 | 118.29 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.9563 | 272.96 | 70.21 | 108.17 | 129.39 |
| 20-Day Raw Stochastic | 1.61% | 0.65% | 3.10% | 63.25% | 3.37% |
| 20-Day Relative Strength | 25.82% | 36.64% | 27.91% | 64.69% | 35.49% |
| Weighted Alpha | -93.98 | +4.25 | -25.27 | +46.30 | -46.00 |
| Today's Opinion | 100% Sell | 56% Sell | 100% Sell | 100% Buy | 72% Sell |
| Previous Opinion | 100% Sell | 56% Sell | 100% Sell | 100% Buy | 72% Sell |
| Last Month's Opinion | 100% Sell | 8% Sell | 88% Sell | 100% Buy | 40% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -19.62% since 04/11/24 | -2.69% since 04/11/24 | -3.63% since 04/11/24 | -1.97% since 11/13/19 | -10.72% since 04/11/24 |
| Low | 0.7000 on 04/17/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 107.27 on 11/20/19 | 115.73 on 04/18/24 |
| High | 0.9265 on 04/12/24 | 270.93 on 04/15/24 | 68.62 on 04/12/24 | 110.53 on 11/14/19 | 134.85 on 04/12/24 |
| 1-Month | |||||
| %Chg | -84.54% since 03/18/24 | -3.01% since 03/18/24 | -9.69% since 03/18/24 | +5.14% since 10/18/19 | -10.34% since 03/18/24 |
| Low | 0.7000 on 04/17/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 102.40 on 10/21/19 | 115.73 on 04/18/24 |
| High | 5.5000 on 03/20/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 110.70 on 11/13/19 | 144.19 on 03/21/24 |
| 3-Month | |||||
| %Chg | -88.55% since 01/18/24 | -13.71% since 01/18/24 | -23.43% since 01/18/24 | +13.63% since 08/20/19 | -13.07% since 01/18/24 |
| Low | 0.7000 on 04/17/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 93.41 on 08/23/19 | 115.73 on 04/18/24 |
| High | 10.8000 on 03/07/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| 6-Month | |||||
| %Chg | -95.03% since 10/18/23 | -7.35% since 10/18/23 | -16.96% since 10/18/23 | +14.14% since 05/20/19 | -6.24% since 10/18/23 |
| Low | 0.7000 on 04/17/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 89.08 on 07/23/19 | 89.00 on 11/10/23 |
| High | 16.5704 on 10/19/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 305 | 141,520,144 | 83,333,008 | 77,035,920 | 18,838,276 |
| Shares Outstanding, K | 428 | 535,919 | 1,245,077 | 711,714 | 159,255 |
| Annual Sales | 0 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
| Annual Net Income | -17,410,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 1,122,000,000 |
| Last Quarter Net Income | -5,900,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | -176,000,000 |
| 60-Month Beta | 4.89 | 0.58 | 0.19 | 1.41 | 1.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -22.03 on 11/14/23 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 0.14 on 02/08/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.24 | 10.02 | 10.99 | 135.28 |